Hygeia Healthcare Holdings Co., Ltd.

Hygeia Healthcare Holdings Co., Ltd.

HHKEX:6078
10.66
HKD
-0.06
(-0.56%)
5.57BMarket Cap
Mar 31Next Earn
Hygeia Healthcare Holdings Co., Ltd.
HKEX:6078
(Hong Kong Exchange)

Recent

price

10.66

P/E

ratio

- -

div

yld

- -

ROIC.AI

2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
CNY
0.99
1.28
1.81
3.14
3.75
5.18
6.46
7.07
6.48
- -
Revenue per Share
-0.08
- -
0.07
0.38
0.71
0.77
1.08
0.95
0.27
- -
Basic EPS, GAAP
-0.27
-0.22
0.11
-0.07
-0.39
0.13
-0.25
0.15
0.75
- -
Free Cash Flow per Basic Share
- -
0.03
- -
0.16
0.12
- -
0.15
- -
- -
- -
Dividend per Share
-0.51
-0.32
-0.34
6.91
7.21
8
9.87
10.72
10.97
11.42
Book Value per Share
-1.16
-0.96
-0.98
6.29
3.36
4.13
3.62
4.37
5.05
5.42
Tangible Book Value per Share
600
600
600
447
618
617
631
629
618
616
Basic Weighted Avg Shares
596
766
1,086
1,402
2,315
3,196
4,077
4,446
4,009
- -
Sales/Revenue/Turnover
6.85
14.17
16.88
22.96
22.63
22.75
21.44
19.96
15.56
- -
Operating Margin (%)
42
49
71
78
114
153
211
295
304
- -
Depreciation Expense
-46
3
40
170
441
477
683
598
165
- -
Net Income, GAAP
- -
91.13
49.87
29.91
20.89
25.09
19.99
20.31
50.68
- -
Effective Tax Rate (%)
-7.78
0.34
3.66
12.13
19.07
14.92
16.75
13.46
4.1
- -
Profit Margin (%)
169
98
-1,046
2,641
866
723
31
30
19
-204
Working Capital
63
45
1
1
1,197
1,106
2,321
2,256
2,002
1,711
LT Debt
-303
-188
-203
4,341
4,478
4,940
6,255
6,674
6,785
6,956
Total Equity
- -
- -
- -
9.98
9.25
8.25
9.22
7.02
2.06
- -
Return on Invested Capital (%)
- -
-5.4
-52.79
9.5
8.91
8.34
9.41
7.11
2.16
- -
Return on Capital (%)
- -
- -
- -
- -
10.12
10.15
12.23
9.29
2.45
- -
Return on Common Equity (%)

Capital Structure

CNY

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
ST Debt
624
444
554
LT Borrowings
2,017
1,996
1,706
LT Finance Leases
8
6
5
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
618
617
608
Market Capitalization
8,613
6,886
4,822

Working Capital

CNY

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
Total Current Assets
1,747
1,703
1,544
Cash, Cash Equivalents & STI
672
695
722
Accounts Receivable, Net
735
687
549
Inventories
178
151
122
Total Current Liabilities
1,816
1,684
1,748
Payables & Accruals
- -
- -
- -
ST Debt
624
444
554
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
9.69%
1.65%
Free Cash Flow
- -
110.2%
406.85%
Net Income, GAAP
- -
25.18%
-72.5%
Sales/Revenue/Turnover
- -
26%
-9.84%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
4,446
2025
- -
- -
4,009
2026
- -
- -
- -

Semi-annual Earnings Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.95
2025
- -
- -
0.27
2026
- -
- -
- -

Semi-annual Dividends Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -
Business
Hygeia Healthcare Holdings Co., Limited (6078.HK) is China's largest oncology-focused healthcare group, owning and operating private for-profit hospitals that provide comprehensive oncology services including radiotherapy, chemotherapy, surgery, targeted therapy, cancer diagnosis, treatment, and rehabilitation; it also offers radiotherapy services to third-party hospitals through consulting, equipment licensing, maintenance, and technical support, alongside hospital management services for private not-for-profit facilities, supply chain operations, and sales of pharmaceuticals, medical consumables, equipment, and proprietary SRT radiotherapy equipment. Founded in 2009 and headquartered in Shanghai, the company primarily serves oncology patients across the People's Republic of China, concentrating operations in the domestic market with a network spanning regions like the Yangtze River Delta and beyond, supported by approximately 8,169 employees. Recent expansions include the openings of Heze Hygeia Hospital and Chongqing Hygeia Hospital in 2024, acquisitions such as a 70% stake in Chang'an Hospital and Datang International (Hong Kong) Limited for CNY 1.2 billion each, an 89.2% stake in Yixing Hygeia Hospital in 2023, and ongoing developments like Wuxi Hygeia Hospital, Changshu Hygeia Hospital, and expansions at Suzhou Yongding Hospital and Qufu Hospital, aiming to grow total hospital beds toward 12,000 by late 2024.